GREENPEAK Partners announces its first acquisition through ACADEMIA group

GREENPEAK is pleased to announce that through their group ACADEMIA, they have made a majority investment in the St. Vinzenz Group, where they could establish a suited shareholder succession. Thanks to the outstanding management, the hospital, as a leading provider of healthcare services in the Allgäu area, has built a remarkable brand in the region showing high patient and employee satisfaction.

With the St. Vinzenz Klinik as a partner, the ACADEMIA group now fulfills the legal prerequisite for executing its strategy of offering quality leaders in the highly fragmented special laboratories (including pathology and human genetics laboratories) market a tailor-made succession plan.

Dirk Kuschmann, CEO of St. Vinzenz Group, comments: “Together with our new partner, we managed to find an ideal shareholder succession laying the foundation for the future growth of St. Vinzenz Group. Also, we are looking forward to supporting ACADEMIA’s plan to establish a leading outpatient special laboratory group.” 

Marcus Geier, CEO of ACADEMIA, commented, “ACADEMIA offers quality leaders in the special laboratory space fair and professional cooperation. Together with the St. Vinzenz carrier clinic, we will build up an integrated and powerful network in the next few years.”

Dr Michael Ruoff, Managing Partner at GREENPEAK and advisory board chairman of ACADEMIA, said, “The St. Vinzenz Group is a premium and high-performance, service provider. We are happy to team up with its professional and experienced management who will support ACADEMIA’s CEO Marcus Geier to combine a powerful special laboratory group in the German healthcare market.”

Daniel Beringer, Managing Partner and speaker at GREENPEAK, commented, “We feel very fortunate that we were able to bring our first group, “ACADEMIA” to life with such a great acquisition.”


The platform ACADEMIA was found to help quality leaders in the special laboratory space with their succession plans. Within the next years, ACADEMIA will build Germany’s first special laboratory group, focusing on, amongst others, pathology, human genetics, and hemostaseology.

About GREENPEAK Partners

GREENPEAK Partners is a company builder with a proven track record and comprehensive expertise in the foundation, development, and expansion of industry leaders in the DACH region. While executing its build-up strategies, GREENPEAK aims to develop solid businesses by establishing close partnerships, ESG values, and aligned interests.